Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Orchid BioSciences, Inc ORCH -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (39)	10/13/2001 9:51:02 PM
From: D.Austin	Respond to of 94

Helllllo Glenn Do you know of Perkin Elmer..They announced a partnership agreement with ORCH over a year ago and I will try to find it after a while. cheers Dennis

To: Glenn Petersen who wrote (39)	10/14/2001 5:00:34 PM
From: Cosmo Daisey	Read Replies (1) \| Respond to of 94

Glen, I had started positioning ORCH last week for other reasons than bio-weapons. I sold the bounce on Fri. and cleared about 5k thinking I can buy it back cheaper in a few days. The announcement over the weekend that more anthrax cases have popped up should send the price higher so perhaps I will have to pay more. I like the stock long term and the analyst price target of $9 is much too low in my view. I also hold NGEN that jumped on the bio-weapons news. I am holding core position and buying any pullbacks. cdaisey@shouldaheldorch.com